¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18
±³À°ÀÏÀÚ : 2020-09-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism      
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í ºñ¸â¹ö ÀÇ»ç 15¸¸¿ø ¸â¹ö ÀÇ»ç 10¸¸¿ø ºñ¸â¹ö ºñÀÇ»ç 10¸¸¿ø ¸â¹ö ºñÀÇ»ç 5¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:10~09:40 SGLT2 inhibition and kidney protection in people without diabetes  David Z. Cherney(TRGRI Canada) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:40~10:10 Anti-diabetes drugs and proteinuria  Soon Hyo Kwon(Soonchunghyang University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:10~10:40 Anti-diabetes drugs and GFR  Sang Soo Kim(Pusan National University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:40~11:10 Multiomics approach in DKD research  Nan Hee Kim(Korea University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ11:30~12:00 Diabetes care: post COVID-19 new normal  Kun-Ho Yoon(The Catholic University of Korea Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ12:00~12:30 Digital transformation of future medicine accelerated by COVID-19  Sungroh Yoon(Seoul National University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ12:50~13:10 Empagliflozin? potential role in T2D & complications  David Z. Cherney(TRGRI Canada) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:00~14:30 Lack of a legacy effect in patients with diabetes and cardiovascular disease  Neda Laiteerapong(The University of Chicago USA) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:30~15:00 Early intensive combination therapy in T2DM: pros and cons  Chang Hee Jung(University of Ulsan Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:00~15:30 Strategy to achieve remission of diabetes: life style and metabolic surgery (direct trial (low calorie diet)  Hyuk Sang Kwon(The Catholic University of Korea Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:30~16:00 Do we need to use SGLT2i/GLP-1RA in well-controlled diabetes with increased CV risk?  Roopa Mehta(INCMNSZ Mexico) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:20~16:50 Blood glucose, antidiabetic drugs, and stroke risk  Meng Lee(Chang Gung University Taiwan) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:50~17:20 Hypoglycemia and brain  Ji-Young Kim(Inje University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:20~17:50 Screening and diagnosis of diabetic peripheral arterial disease  Pil Hyung Lee(University of Ulsan Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:50~18:20 Update of current treatment of diabetic peripheral arterial disease  Su Hong Kim(Busan Veterans Hospital Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¦ 19 ȸ ºÎ»ê°æ³²Áßµ¶¿¬±¸È¸(ASBK) ¼¼¹Ì³ª & Çѱ¹Áßµ¶Á¤½ÅÀÇÇÐȸ ½ÉÆ÷Áö¾ö : 2020-09-18
´ÙÀ½±Û (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦76Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2020) 2ÀÏÂ÷ : 2020-09-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
77 ±¤ÁÖ Á¦30Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2018-08-19 0 751 2018-07-28
76 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦ 3ȸ Current Concepts and Techniques In Knee Surgery (CCTIKS) -SMC Live Surgery & Symposium- : 2018-08-19 0 658 2018-07-28
75 ¼­¿ï 2018 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰú ¿¬¼ö°­Á : 2018-08-19 0 801 2018-07-28
74 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-19 0 897 2018-07-28
73 ´ë±¸ ´ëÇѳ»°úÇÐȸ Á¦18ȸ ³»°úÀü¹®ÀÇ Æò»ý±³À° ¿¬¼ö°­Á : 2018-08-19 0 506 2018-07-28
72 ¼­¿ï ´ëÇѼҾÆû¼Ò³âÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¼ºÀÎADHD¿¬±¸È¸ "¼ºÀÎ ADHD Áø·áÀÇ ½ÇÀü ±æ¶óÀâÀÌ" : 2018-08-19 0 847 2018-07-28
71 ¼­¿ï Á¦3ȸ ´ëÇѼҾÆû¼Ò³â°úÀÇ»çȸ ÃÊÀ½ÆÄ¿öÅ©¼¥ : 2018-08-19 0 608 2018-07-28
70 ¼­¿ï ´ëÇѺñ°úÇÐȸ RHINOLOGY UPDATE SYMPOSIUM IN 2018 : 2018-08-18 0 466 2018-07-28
69 ´ë±¸ 2018³âµµ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö±³À° : 2018-08-18 0 457 2018-07-28
68 °æ±â 2018 °í·Á´ëÇб³¾È»êº´¿ø °¡Á¤ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2018-08-18 0 696 2018-07-28
67 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Highlighted Access on Disease Recurrence Of Cervical cancer(HADROC) Symposium : 2018-08-18 0 615 2018-07-28
66 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ ¿¬¼ö°­Á : 2018-08-18 0 578 2018-07-28
65 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ TEE Workshop : 2018-08-18 0 725 2018-07-28
64 ºÎ»ê ´ëÇѽɺÎÀüÇÐȸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-18 0 582 2018-07-28
63 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦7ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²²ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¿ò : 2018-08-18 0 889 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷